Stockreport

Bayer Aktiengesellschaft Touts Pharma Turnaround at JPM Healthcare, Lifts 2025 Outlook Despite Xarelto LOE [Yahoo! Finance]

BAYER AG S/ADR  (BAYRY) 
NASDAQ:AMEX Investor Relations: investor.bayer.com
PDF Morgan Healthcare Conference that the company's pharmaceutical business is showing “clear proof points” of a turnaround, pointing to updated 2025 guidance, a reshaped pr [Read more]